Search

Headquarters

Contact Us

  • (+01) 512 835 8026
  • 3300 Duval Road
    Austin, TX 78759
    USA
  • Mon to Fri - 8:50am to 5:00pm

Ready to order?

Great! Every order starts with a quote.

Get Started 

  • (+01) 512 835 8026
  • Email Us
Get a Quote Contact | FAQ's | Blog
Rules-Based Medicine Rules-Based Medicine

a Q<sup>2</sup> Solutions Company

Toggle menu

Skip to content
  • About Us
    • About RBM

      Rules-Based Medicine (RBM), a Q2 Solutions Company, is a CLIA certified, multiplexed immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services.
    • About RBM

      • About Us
      • Our Scientists
      • Quality Policy
      • Employment
      • Partners
      • Sales Team
      • Certifications
    • Newsroom

      • Press
      • Company Newsletters
      • Conferences
      • Abstracts + Papers
      • Sign Up for Our Newsletter
      • Blog
    • Data Quality

      • Overview
      • RBM Technology
  • Biomarker Solutions
    • Solutions

      • Overview
      • Assay Change Log

      CustomMAP

      If a smaller, more focused panel of analytes is required, we can build a Custom MAP to meet your needs.

      Learn More »

      TruCulture Spike

    • Multiplexed Immunoassays

      • Full Biomarker Menu
      • DiscoveryMAP® v. 4.0
      • ExplorerMAP™ v. 1.0
      • HumanMAP® v. 2.0
      • CardiovascularMAP® v. 3.0
      • AngiogenesisMAP® v. 1.0
      • InflammationMAP® v. 1.1
      • ImmunoMAP® v. 1.0
      • MetabolicMAP® v. 1.0
      • KidneyMAP®
      • CytokineMAP A
      • CytokineMAP B
      • SARS-CoV-2/COVID-19 Research
      • Cytokine Storm Testing for SARS-CoV-2/COVID-19 Research
    • TruCulture

      Whole Blood Collection and Culture System

      Learn More »
      Quanterix simoa

      Ultrasensitive immunoassays manufactured by RBM and based on Quanterix’s Simoa technology.

      Learn More »
  • Resources + Support
    • Resources

      • Bibliography
      • White Papers
      • Application Notes
      • Events
      • Webinars
      • Blog
      • COVID-19/SARS-CoV-2 Research Tools
    • Support

      • Client Services
      • Request a Biomarker
      • Speak to a Scientist
  • How to Order
    • Ordering Information

      • How to Order
      • Request a quote
      • Acceptable Samples
      • Frequently Asked Questions
    • Request Information

      • Contact Client Services
      • Request a Biomarker
      • Speak to a Scientist
    • Ready to Order?

      Great!

      Every order starts with a quote.

      Get Started

Category Archives: Blog

9 May 2012

Myriad RBM Expands Its Biomarker Panel for Oncology

May 9, 2012
Desiree Klingler-Gaston
Blog, Cancer, Utilized Rules-Based Medicine's Services
Cancer is a remarkably complex disease that can affect nearly every system and pathway in the body. A new panel of biomarkers from Myriad RBM (Oncolog...
Read More
1 May 2012

Do Biomarkers for Traumatic Brain Injury Overlap with Other Neurodegenerative Disorders?

May 1, 2012
Desiree Klingler-Gaston
Blog, Neuroscience and Neurological
A Swedish group of researchers has published a study taking a look at CSF biomarkers following repetitive head trauma. After collecting samples from O...
Read More
1 May 2012

Video Feature OncologyMAP v.2.0

May 1, 2012
Desiree Klingler-Gaston
Cancer
...
Read More
11 Apr 2012

Major Depression and Alzheimer’s Disease: A common link?

April 11, 2012
Desiree Klingler-Gaston
Blog, Neuroscience and Neurological
The association between depression and AD is not new but a new article published in The American Journal of Psychiatry offers a look into one possible...
Read More
22 Feb 2012

Breast Cancer Protein Linked to Metastasis

February 22, 2012
Desiree Klingler-Gaston
Blog, Cancer
A new study published in the Journal of American Pathology underscores the importance of understanding the role that a biomarker target plays in both...
Read More
14 Feb 2012

Blood-based or CSF-based?

February 14, 2012
Desiree Klingler-Gaston
Blog, Neuroscience and Neurological
Do you think drug development groups and clinical researchers would rather have a biomarker discovery tool for neurodegenerative disease that is blood...
Read More
8 Feb 2012

How soon do Alzheimer’s biomarkers start taking their toll?

February 8, 2012
Desiree Klingler-Gaston
Blog, Neuroscience and Neurological
Currently, hopes of preventing the worst of the decline seen with Alzheimer's disease lie in the early detection or identifying those who are predispo...
Read More
1 … 15 16 17 18 19 20

Categories

  • Biomarkers (4)
  • Blog (134)
    • Autoimmune and Arthritis (10)
    • Cancer (28)
    • Cardiac (9)
    • Cytokines and Chemokines (20)
    • Diabetes (7)
    • Gastrointestinal (1)
    • Inflammation (42)
    • Neuroscience and Neurological (33)
    • News From the Lab (1)
    • Renal Function and Toxicity (8)
    • Technology- Multi-Analyte Profile (1)
    • TruCulture (2)
  • COVID-19 (1)
  • Press (37)
  • Utilized Rules-Based Medicine's Services (43)

ABOUT RBM

Overview
Our Scientists
Quality Policy
Employment
Partners
Sales Team
Certifications

A Q2 Solutions Company

Contact Us

Q2 Solutions, a wholly owned subsidiary and laboratory division of IQVIA, is a leading global clinical trial laboratory services organization providing comprehensive testing, project management, supply chain, biorepository and specimen management, and clinical trial sample and consent tracking solutions. Learn more at www.q2labsolutions.com.

MAPs

Full Biomarker Menu
DiscoveryMAP® v. 3.3
ExplorerMAP™ v. 1.0
HumanMAP® v. 2.0
CardiovascularMAP® v. 3.0
AngiogenesisMAP® v. 1.0
InflammationMAP® v. 1.0
ImmunoMAP® v. 1.0
NeuroMAP™ v. 1.0
MetabolicMAP® v. 1.0
KidneyMAP®
CytokineMAP A
CytokineMAP B

RESOURCES

Bibliography
White Papers
Events
Webinars
Blog

SUPPORT

Customer Support
Speak to a Scientist
Assay Change Log
Request a Biomarker
FAQs

SOLUTIONS

Results Processing
Assay Development
Quality Control
Project Management

SERVICES

Multiplexed Assay Services
Ultrasensitive Assays
TruCulture

  • Jobs
  • Terms of Use
  • Privacy Practice
  • Analytes Listing
Copyright © 2022 Rules-Based Medicine. All rights reserved. RBM does not sell your personal information